UiPath Inc (PATH) Stock Price Today
Aura AI Summary
Key Stats
- $6.23BMarket Cap
- -Volume
- TechnologySector
- $19.2952W High
- $9.3852W Low
- -Typical Hold Time
- $5.01BEnterprise Value
- -Div Yield
- -Trading Activity
Track UiPath Inc (PATH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, UiPath Inc has traded between a low of $9.38 and a high of $19.29, highlighting its annual price range. Buy and sell UiPath Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Most Recent News
Jackery launches FridgeGuard, a smart fridge backup power, now exclusive at Costco.
Jackery has introduced FridgeGuard, the world's slimmest refrigerator backup power system, now available exclusively at Costco. Designed to protect refrigerators during power outages, it offers up to 15 hours of backup runtime, covering the average U...

Mass spectrometry market to double to $14.09B by 2035, driven by pharma and biotech growth
The global mass spectrometry market, valued at $6.68 billion in 2025, is projected to grow to $14.09 billion by 2035 at a CAGR of 7.74%. Growth is fueled by increased adoption in pharmaceutical manufacturing, biotechnology research, clinical diagnost...

Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growth
The global cancer biomarkers market is projected to grow from $28.25 billion in 2026 to $54.48 billion by 2032, at an 11.6% CAGR. Growth is fueled by rising cancer rates, technological advances like multi-omics and AI integration, and increased deman...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.